Did you know that 22% of Americans are undermethylated and another 8% are overmethylated? The emerging science of epigenetics is providing insights into the impact of methylation imbalances on neurotransmission at serotonin, dopamine, norepinephrine, and NMDA receptors, and also provides a roadmap for effective nutrient therapies. William J. Walsh, PhD, presents The Role of Methylation and Epigenetics in Brain Disorders.
For more information, visit www.walshinstitute.org.
To find a practitioner, visit www.walshinstitute.org/clinical-resources.html